Trevi Health Ventures

Trevi invests from seed and start-up venture through late-stage growth equity and buyout recapitalizations, all within the healthcare sector. This multi-stage approach allows the firm to back companies from early clinical development through commercial maturity. The strategy spans early-stage venture, expansion and late-stage financing, and control-oriented investments.

Trevi is headquartered in New York and primarily invests in US-based healthcare companies. The firm has indicated capacity to evaluate opportunities in major European markets, suggesting a transatlantic mandate. No specific European portfolio companies have been publicly confirmed.

Trevi evaluates opportunities across digital health, healthcare services, and biopharmaceuticals. The firm's seed and early-stage activity targets emerging therapeutics platforms and healthtech startups, while its growth and buyout practices focus on established healthcare-services companies. The firm does not publicly exclude any healthcare subsector.

Trevi has not publicly disclosed its named principals, investment committee members, or key decision-makers. No managing partner, CEO, or CIO is identified in public record. This opacity is consistent with smaller private equity firms that operate without an institutional marketing function.

Trevi is categorized as an asset manager operating a private equity mandate, not a single-family or multi-family office. The firm deploys third-party institutional capital across a multi-stage healthcare strategy. Its fund structure and limited partner relationships are not publicly disclosed.